Guzmán CR, Baeza BR, Espinosa PSE

Language: Spanish
References: 18
Page: 24-27
PDF size: 139.32 Kb.

ABSTRACT

Primary immunodeficiencies are a heterogeneous group of congenital diseases of the immune system that lead to recurrent infections, autoimmunity, malignancies, and hematologic disorders. This review focuses specifically on congenital disorders associated with neutropenia, which can occur in isolation or as a feature of more complex immune disorders and specifically on quantitative neutrophil defects.

REFERENCES

1. Rosmarin AG, Yang Z, Resendes KK. Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp Hematol. 2005; 33: 131-143.

2. Hauck F, Klein C. Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol. 2013; 13 (6): 596-606.

3. Elhasid R, Hofbauer LC, Ish-Shalom S et al. Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. Am J Hematol. 2003; 72 (1): 34-37.

4. Paz Z, Nails M, Ziv E. The genetics of benign neutropenia. Isr Med Assoc J. 2011; 13: 625-629.

5. Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011; 6: 26.

6. McDermott DH, Liu Q, Ulrick J et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood. 2011; 118: 4957-4962.

7. Thrasher AJ. New insights into the biology of Wiskott-Aldrich syndrome (WAS). Hematology Am Soc Hematol Educ Program. 2009; 132-138.

8. Ferri L, Donati MA, Funghini S et al. New clinical and molecular insights on Barth syndrome. Orphanet J Rare Dis. 2013; 8: 27.

9. Arnold AW, Itin PH, Pigors M, Kohlhase J, Bruckner-Tuderman L, Has C. Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria. Br J Dermatol. 2010; 163: 866-869.

10. Norio R, Raitta C, Lindahl E. Further delineation of the Cohen syndrome; report on chorioretinal dystrophy, leukopenia and mconsanguinity. Clin Genet. 1984; 25: 1-14.

11. Carlsson G, van't Hooft I, Melin M et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. Intern Med. 2008; 264: 388-400.

12. Wijermans PW, van Dorp DB. Hermansky-Pudlak syndrome: correction of bleeding time by 1-desamino-8Darginine vasopressin. Am J Hematol. 1989; 30: 154-157.

13. Spinner MA, Sanchez LA, Hsu AP et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014; 123: 809-821.

14. Boztug K, Appaswamy G, Ashikov A et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009; 360: 32-43.

15. Dror Y, Donadieu J, Koglmeier J et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011; 1242: 40-55.

16. Skokowa J, Steinemann D, Katsman- Kuipers JE et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014; 123: 2229-2237.

17. Wali Y, Beshlawi I, Fawaz N et al. Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving. Eur J Haematol. 2012; 89 (3): 245-2499.

18. Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012; 19: 44-51.